In the wake of a global pandemic, the life sciences industry has risen to the occasion, supplying vital medicines, developing new therapeutics, diagnostics and vaccines in the fight against COVID-19. However, it’s also disrupted research, clinical trials and supply chains at a time when the sector was contending with significant challenges, including financial.
Operational and cost efficiency is more important now than ever. As the third-largest expense for most life sciences companies, real estate and facilities are key areas that can help minimize or avoid expenses and increase capital. Implementing strategies that reduce costs and improve cash flow will open up much-needed resources to invest in R&D, while helping your company grow and reach goals.
JLL’s guidebook, 14 real estate strategies to reduce costs and fuel Life Sciences R&D, provides numerous levers that will help you reduce your costs, recapture your revenue and thrive, including:
Thank you for your interest in the guide! Click below to get your copy.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again